Two Day Conference: FDA's New Import Program for 2018 - Strict Precision (San Francisco, CA, United States - October 4-5, 2018) - ResearchAndMarkets.com
Aug. 10, 2018
DUBLIN--(BUSINESS WIRE)--Aug 10, 2018--The "FDA's New Import Program for 2018 - Strict Precision" conference has been added to ResearchAndMarkets.com's offering.
The FDA continues to change its import program to better manage new problems and to use new procedures to make the whole process easier. The FDA and U.S. Customs and Border Protection (CBP) are relying more and more on computer programs to expedite the import process. When and how you use these programs can make a big difference in the net profit derived from even a single shipment. The new Voluntary Qualified Importer Program (VQIP) is one such example.
Another example is CBP's and FDA's implementation of the Automated Commercial Environment (ACE) program became mandatory for importers in 2016. If you fail to correctly use new import procedures and programs, you will be operating under an expensive disadvantage.
Learning Objectives:FDA's new cost-saving import programs Understand how U.S. Customs and FDA legal requirements intersect Know how to manage foreign suppliers Understand FDA's internal procedures Learn how to mitigate and resolve import detentions Learn how to avoid common problems Develop practical ways to improve your import and export business You will be able to answer the following questions with this course without saying, I don't know? What are the FDA's import legal requirements and policy? How do you deal with the FDA and the U.S. Customs and Border Patrol procedures? What happens when your product is detained? What happens if a foreign manufacturer is in trouble with the FDA? How do you inter-act with the FDA to work out problems? Why are import and export rules different or does it even matter?
Who Should Attend:
The FDA's regulatory controls for imported and exported devices have become increasingly pervasive and stringent. Foreign manufacturers, foreign exporters and domestic initial importers face greater scrutiny and are subject to expensive consequences if they do not plan carefully. Attendees need to understand the FDA's and the US Customs Border Patrol's regulatory criteria, inter-agency agreements and intra-agency procedures.
The conference provides attendees with the opportunity to understand their work's inter-relationship with other attendees' roles:Business Planning Executives Regulatory Managers In-house Legal Counsel and Contract Specialists Venture Capitalists Business Acquisition Executives Owners of New or Developing Import/Export Firms International Trade Managers Import Brokers Investors Logistics Managers Sales Managers
For more information about this conference visit https://www.researchandmarkets.com/research/79mhkx/two_day?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180810005179/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Medical Devices
KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA
INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES PHARMACEUTICAL FDA
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 08/10/2018 07:43 AM/DISC: 08/10/2018 07:43 AM